Buis Lorraine R, Roberson Dana N, Kadri Reema, Rockey Nicole G, Plegue Melissa A, Choe Hae Mi, Richardson Caroline R
Department of Family Medicine, University of Michigan, Ann Arbor, MI, United States.
University of Michigan Medical Group, Pharmacy Innovations and Partnerships, Ann Arbor, MI, United States.
JMIR Res Protoc. 2017 Oct 10;6(10):e193. doi: 10.2196/resprot.8059.
Hypertension (HTN) is a major public health concern in the United States given its wide prevalence, high cost, and poor rates of control. Multiple strategies to counter this growing epidemic have been studied, and home blood pressure (BP) monitoring, mobile health (mHealth) interventions, and referrals to clinical pharmacists for BP management have all shown potential to be effective intervention strategies.
The purpose of this study is to establish feasibility and acceptability of BPTrack, a clinical pharmacist-led mHealth intervention that aims to improve BP control by supporting home BP monitoring and medication adherence among patients with uncontrolled HTN. BPTrack is an intervention that makes home-monitored BP data available to clinical pharmacists for use in HTN management. Secondarily, this study seeks to understand barriers to adoption of this intervention, as well as points of improvement among key stakeholders, so that larger scale dissemination of the intervention may be achieved and more rigorous research can be conducted.
This study is recruiting up to 25 individuals who have poorly controlled HTN from a Family Medicine clinic affiliated with a large Midwestern academic medical center. Patient participants complete a baseline visit, including installation and instructions on how to use BPTrack. Patient participants are then asked to follow the BP monitoring protocol for a period of 12 weeks, and subsequently complete a follow-up visit at the conclusion of the study period.
The recruitment period for the pilot study began in November 2016, and data collection is expected to conclude in late-2017.
This pilot study seeks to document the feasibility and acceptability of a clinical pharmacist-led mHealth approach to managing HTN within a primary care setting. Through our 12-week pilot study, we expect to lend support for this approach, and lay the foundation for translating this approach into wider-scale implementation. This mHealth intervention seeks to leverage the multidisciplinary care team already in place within primary care, and to improve health outcomes for patients with uncontrolled HTN.
Clinicaltrials.gov NCT02898584; https://clinicaltrials.gov/ct2/show/NCT02898584 (Archived by WebCite® at http://www.webcitation.org/6u3wTGbe6).
鉴于高血压（HTN）在美国广泛流行、成本高昂且控制率低，它是一个主要的公共卫生问题。人们已经研究了多种应对这一日益严重的流行病的策略，家庭血压（BP）监测、移动健康（mHealth）干预以及将患者转介给临床药剂师进行血压管理都显示出可能是有效的干预策略。
本研究的目的是确定BPTrack的可行性和可接受性，BPTrack是一种由临床药剂师主导的移动健康干预措施，旨在通过支持家庭血压监测和提高未控制高血压患者的药物依从性来改善血压控制。BPTrack是一种使家庭监测的血压数据可供临床药剂师用于高血压管理的干预措施。其次，本研究旨在了解采用这种干预措施的障碍以及关键利益相关者之间的改进点，以便能够实现该干预措施的更大规模传播并开展更严格的研究。
本研究正在从一家与中西部大型学术医疗中心相关的家庭医学诊所招募多达25名血压控制不佳的个体。患者参与者完成一次基线访视，包括BPTrack的安装和使用说明。然后要求患者参与者遵循血压监测方案12周，并在研究期结束后完成一次随访访视。
试点研究的招募期于2016年11月开始，预计数据收集将于2017年末结束。
这项试点研究旨在记录在初级保健环境中由临床药剂师主导的移动健康方法管理高血压的可行性和可接受性。通过我们为期12周的试点研究，我们期望为这种方法提供支持，并为将这种方法转化为更广泛的实施奠定基础。这种移动健康干预措施旨在利用初级保健中已经存在的多学科护理团队，并改善未控制高血压患者的健康结果。
Clinicaltrials.gov NCT02898584；https://clinicaltrials.gov/ct2/show/NCT02898584（由WebCite®存档于http://www.webcitation.org/6u3wTGbe6）。
